SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif. & ...
Agilent Technologies Inc. and Cogenics, a division of Clinical Data, Inc. have announced that Cogenics has been recertified, for the third year, as a Certified Microarray Service Provider for Agilent ...
PALO ALTO, Calif., July 18, 2006, Agilent Technologies Inc. (NYSE: A) today announced the availability of its new SurePrint microarrays, which contain more than 240,000 features. These DNA microarrays ...
PALO ALTO, Calif., Aug. 7, 2006, Agilent Technologies Inc. (NYSE: A) today announced the availability of oligo array-based ChIP-on-chip (chromatin immunoprecipitation on a chip) microarrays with a ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...
The Microarray Core Facility is a component of the UAlbany Center for Functional Genomics and was established to provide the infrastructure to enable the development of major projects that utilize DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results